美国FDA生物制品紫皮书数据库
(U.S. FDA Purple Book: Database of Licensed Biological Products)
商品名 申请号 产品号 BLA类型 非专利名称 剂型 给药途径 规格/剂量 产品形式 批准日期 申请人 市场状态 许可证状态 参考产品非专利名称 参考产品专利名称
Novoseven, Novoseven Rt 103665 001 351(a) Coagulation Factor VIIa (Recombinant) For Injection Intravenous 2.4MG Single-Dose Vial 1999/03/25 Novo Nordisk Inc. Disc Licensed N/A
Actimmune 103836 001 351(a) interferon gamma-1b Injection Subcutaneous 100MCG(2MILLION INTERNATIONAL UNITS)/0.5ML Single-Dose Vial 1999/02/25 Horizon Therapeutics Ireland DAC Rx Licensed N/A N/A
Ontak 103767 001 351(a) denileukin diftitox Injection Intravenous 150MCG/ML (300MCG/2ML) Single-Dose Vial 1999/02/05 Eisai, Incorporated Disc Licensed N/A N/A
Humatrope 019640 005 351(a) somatropin For Injection Subcutaneous 6MG Multi-Dose Cartridge 1999/02/04 Eli Lilly and Company Rx Licensed N/A N/A
Humatrope 019640 006 351(a) somatropin For Injection Subcutaneous 12MG Multi-Dose Cartridge 1999/02/04 Eli Lilly and Company Rx Licensed N/A N/A
Humatrope 019640 007 351(a) somatropin For Injection Subcutaneous 24MG Multi-Dose Cartridge 1999/02/04 Eli Lilly and Company Rx Licensed N/A N/A
Thyrogen 020898 001 351(a) thyrotropin alfa For Injection Intramuscular 0.9MG Single-Dose Vial 1998/11/30 Genzyme Corporation Rx Licensed N/A N/A
Biorab 103820 001 351(a) Rabies Vaccine Adsorbed Injection Intramuscular 1.0ML Vial 1998/11/12 Emergent BioDefense Operations Lansing LLC Disc Licensed N/A
Biothrax 103821 001 351(a) Anthrax Vaccine Adsorbed Injection Intramuscular 0.5ML Multi-Dose Vial 1998/11/12 Emergent BioDefense Operations Lansing LLC Rx Licensed N/A
Biothrax 103821 002 351(a) Anthrax Vaccine Adsorbed Injection Subcutaneous 0.5ML Multi-Dose Vial 1998/11/12 Emergent BioDefense Operations Lansing LLC Rx Licensed N/A
Fluvirin 103837 001 351(a) Influenza Virus Vaccine Injection Intramuscular 15UG/.5ML Pre-Filled Syringe 1998/11/03 Seqirus Vaccines Limited Disc Licensed N/A
Enbrel 103795 001 351(a) etanercept For Injection Subcutaneous 25MG Single-Dose Vial 1998/11/02 Immunex Corporation Disc Licensed N/A N/A
Verluma 103769 001 351(a) nofetumomab Injection Intravenous 10MG/ML 1998/10/13 Boehringer Ingelheim Pharma GmbH & Co. KG Disc Voluntarily Revoked N/A N/A
Herceptin 103792 001 351(a) trastuzumab For Injection Intravenous 420MG Multi-Dose Vial 1998/09/25 Genentech, Inc. Disc* Licensed N/A N/A
Remicade 103772 001 351(a) infliximab For Injection Intravenous 100MG Single-Dose Vial 1998/08/24 Janssen Biotech, Inc. Rx Licensed N/A N/A
Humulin R U-100 018780 003 351(a) insulin human Injection Subcutaneous 300UNITS/3ML (100UNITS/ML) Autoinjector 1998/08/06 Eli Lilly and Company Disc Licensed N/A N/A
Humalog 020563 002 351(a) insulin lispro Injection Subcutaneous 300UNITS/3ML (100UNITS/ML) Multi-Dose Cartridge 1998/08/06 Eli Lilly and Company Disc Licensed N/A N/A
Infasurf 020521 001 351(a) calfactant Suspension Intratracheal 210MG/6ML (35MG/ML) Single-Dose Vial 1998/07/01 ONY Biotech Inc. Rx Licensed N/A N/A
Synagis 103770 001 351(a) palivizumab For Injection Intramuscular 50MG Single-Dose Vial 1998/06/19 Swedish Orphan Biovitrum AB (publ) Disc Licensed N/A N/A
Synagis 103770 002 351(a) palivizumab For Injection Intramuscular 100MG Single-Dose Vial 1998/06/19 Swedish Orphan Biovitrum AB (publ) Disc Licensed N/A N/A
当前数据更新日期:2026年02月10日,更多信息请点击此处查询美国FDA药品数据库

数据库说明:

©2006-2026 DrugFuture->U.S. FDA Purple Book